Company intelligence / Profile preview

Belle Pharm

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Belle Pharma is a clinical-stage biopharmaceutical company primarily focused on the development of innovative therapies for dermatological and autoimmune conditions. The company maintains a robust pipeline of small molecules and biologics targeting high-value mechanisms such as IL-17 and JAK pathways. Its lead programs are currently undergoing clinical evaluation for indications including plaque psoriasis and atopic dermatitis. Belle Pharma aims to address significant unmet medical needs in the global dermatology market through its specialized R&D capabilities based in China and the United States.

Therapeutic areas: Dermatology
Modalities: Small moleculeMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Belle Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Belle Pharm.

Explore the full profile